PMAM
DMIIR

Picton Mahoney Asset Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Picton Mahoney Asset Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70K Hold
875,000
– – ﹤0.01% 922
2025
Q4 		$123K Buy
+875,000
New +$125K ﹤0.01% 850

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Picton Mahoney Asset Management's DMIIR Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q1 2026 at 875,000 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Picton Mahoney Asset Management first reported a position in DMIIR in Q4 2025 and has held it in 2 quarters since. The position peaked at $123K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • Picton Mahoney Asset Management held 875,000 shares of Drugs Made In America Acquisition II Corp Right worth $70K as of Q1 2026.
  • Picton Mahoney Asset Management left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q1 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #922 holding.
  • Picton Mahoney Asset Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 2 quarters since.
  • Picton Mahoney Asset Management's Drugs Made In America Acquisition II Corp Right position peaked at $123K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.